Evidence map›Paper›PMID 42819571›Full record

ArticleHemaSphere2026

Chemoimmunotherapy-associated CD20 (

Alberto Guijosa, Nickolas Tsakmaklis, Sirano Dhe-Paganon, Filip Garbicz, Ruben Carrasco, John Hatcher, Andres Ramirez-Gamero, Dominic Pizzarella, Amanda Kofides, Shirong Liu and 9 more

Abstract readLetter
In one paragraph

Article in HemaSphere, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Alberto GuijosaBing Center for Waldenström's Macroglobulinemia Dana-Farber Cancer Institute Boston MA USA.ORCID https://orcid.org/0000-0002-8205-6643
Nickolas TsakmaklisBing Center for Waldenström's Macroglobulinemia Dana-Farber Cancer Institute Boston MA USA.
Sirano Dhe-PaganonBing Center for Waldenström's Macroglobulinemia Dana-Farber Cancer Institute Boston MA USA.
Filip GarbiczDepartment of Medicine Harvard Medical School Boston MA USA.ORCID https://orcid.org/0000-0002-5548-1564
Ruben CarrascoDepartment of Medicine Harvard Medical School Boston MA USA.
John HatcherBing Center for Waldenström's Macroglobulinemia Dana-Farber Cancer Institute Boston MA USA.ORCID https://orcid.org/0000-0002-3540-7842
Andres Ramirez-GameroDepartment of Medicine Roger Williams Medical Center Providence RI USA.
Dominic PizzarellaBing Center for Waldenström's Macroglobulinemia Dana-Farber Cancer Institute Boston MA USA.
Amanda KofidesBing Center for Waldenström's Macroglobulinemia Dana-Farber Cancer Institute Boston MA USA.ORCID https://orcid.org/0009-0009-5120-789X
Shirong LiuBing Center for Waldenström's Macroglobulinemia Dana-Farber Cancer Institute Boston MA USA.ORCID https://orcid.org/0000-0002-3821-9134
Hao SunBing Center for Waldenström's Macroglobulinemia Dana-Farber Cancer Institute Boston MA USA.ORCID https://orcid.org/0000-0002-9081-0116
Xia LiuBing Center for Waldenström's Macroglobulinemia Dana-Farber Cancer Institute Boston MA USA.
María L GuerreraBing Center for Waldenström's Macroglobulinemia Dana-Farber Cancer Institute Boston MA USA.ORCID https://orcid.org/0000-0002-0730-4678
Andrew R BranaganDepartment of Medicine Harvard Medical School Boston MA USA.ORCID https://orcid.org/0000-0002-3868-9267
Gottfried von KeudellDepartment of Medicine Harvard Medical School Boston MA USA.
Shayna R SarosiekBing Center for Waldenström's Macroglobulinemia Dana-Farber Cancer Institute Boston MA USA.ORCID https://orcid.org/0000-0002-0075-6735
Jorge J CastilloBing Center for Waldenström's Macroglobulinemia Dana-Farber Cancer Institute Boston MA USA.ORCID https://orcid.org/0000-0001-9490-7532
Zachary R HunterBing Center for Waldenström's Macroglobulinemia Dana-Farber Cancer Institute Boston MA USA.ORCID https://orcid.org/0000-0002-1689-1691
Steven P TreonBing Center for Waldenström's Macroglobulinemia Dana-Farber Cancer Institute Boston MA USA.ORCID https://orcid.org/0000-0001-6393-6154

Funding

High-Throughput DNA Sequencing SystemS10OD036228 · OD · DANA-FARBER CANCER INST · PI HERBERT, ZACHARY T · 2024 to 2024
$1.0M
NIH HHS S10 OD036228
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID42819571
PMCPMC13626146

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.